UNIMED stock raises its dividend despite lower 2025 profit
Published on 10/04/2026 at 11:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUNIMED (TN0007720014) stock was last quoted at TND 8.80 on the Bourse de Tunis on October 2, 2026, with a 52-week range of TND 7.90 to TND 11.00. The company approved a TND 0.625 dividend for fiscal 2025, a 9.6 percent increase from the prior year's TND 0.570 distribution, according to Terafinances.
Dividend rises as profit declines
The payout decision came despite lower earnings. According to Terafinances, individual net income fell 8.8 percent to TND 16.8 million in fiscal 2025 from TND 18.5 million in fiscal 2024. The approved dividend represented TND 20.0 million in total, equal to 118.8 percent of individual net income.
That distribution ratio means UNIMED is using accumulated reserves to supplement the year's profit. The dividend was scheduled for payment from September 11, 2026, after a September 9 detachment date, as reported by Terafinances.
Revenue growth remains limited
UNIMED's fiscal 2025 revenue increased 1 percent to TND 148.9 million from TND 147.7 million in fiscal 2024, while consolidated net income declined 4 percent to TND 18.6 million from TND 19.4 million, according to Terafinances. The figures show a wider gap between sales growth and profit development than the dividend increase alone suggests.
Analyst target exceeds market price
Investing.com lists one analyst with a Sell consensus and a 12-month average price target of TND 10.60. The page displays both the high and low target at TND 10.60, placing the target 20.45 percent above the TND 8.80 reference price.
Stock remains below yearly high
UNIMED stock stood at TND 8.80 on the Bourse de Tunis on October 2, 2026, against a TND 7.90 to TND 11.00 52-week range and a market capitalization of TND 281.6 million. The latest quote page shows 40,940 shares in volume, giving investors a dated market-value reference alongside the fiscal 2025 dividend and earnings figures.
UNIMED stock at a glance
- Company: Unite de Fabrication de Medicaments SA
- ISIN: TN0007720014
- Ticker: UMED
- Trading venue: Bourse de Tunis
- Price (as of October 2, 2026): TND 8.80
- Market capitalization: TND 281.6 million (as of October 2, 2026)
- 52-week range: TND 7.90-11.00 (as of October 2, 2026)
- Sector / Industry: Health / Pharmaceuticals
